Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli

Protein Expression and Purification

Volumn 24, Issue 3, 2002, Pages 329-337

  Yamazaki, Hiroshi ^a,f   Nakamura, Mami ^a   Komatsu, Tomoko ^a   Ohyama, Katsuhiro ^a   Hatanaka, Naoya ^a   Asahi, Satoru ^b   Shimada, Noriaki ^c   Guengerich, F Peter ^d   Shimada, Tsutomu ^e   Nakajima, Miki ^a   Yokoi, Tsuyoshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^c DAIICHI PURE CHEMICALS CO LTD   (Japan)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^f HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; INSECTA;

EID: 0036447583     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.2001.1578     Document Type: Article

References (40)

1. Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsalus, I. C., and Nebert, D. W. (1996) P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6, 1-42.
2. Guengerich, F.P. (1995) Human cytochrome P450 enzymes in "Cytochrome P450" (Oritiz de Montellano, P.R., Ed.), pp. 473-535, Plenum, New York.
3. Guengerich, F. P., and Shimada, T. (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 4, 391-407.
4. Gonzalez, F. J., Crespi, C. L., and Gelboin, H. V. (1991) cDNA-expressed human cytochrome P450s: A new age of molecular toxicology and human risk assessment. Mutat. Res. 247, 113-127.
5. Crespi, C. L. (1995) Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological research. Adv. Drug Res. 26, 179-235.
6. Renaud, J. P., Peyronneau, M. A., Urban, P., Truan, G., Cullin, C., Pompon, D., Beaune, P., and Mansuy, D. (1993) Recombinant yeast in drug metabolism. Toxicology 82, 39-52.
7. Imaoka, S., Yamada, T., Hiroi, T., Hayashi, K., Sakai, T., Yabusaki, Y., and Funae, Y. (1996) Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat. Biochem. Pharmacol. 51, 1041-1050.
8. Buters, J., Korzekwa, K. R., Kunze, K. L., Omata, Y., Hardwick, J. P., and Gonzalez, F. J. (1994) cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus. Drug Metab. Dispos. 22, 688-692.
9. Lee, C. A., Kadwell, S. H., Kost, T. A., and Serbjit-Singh, C. J. (1995) CYP3A4 expressed by insect cells infected with a recombinant baculovirus containing both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4. Arch. Biochem. Biophys. 319, 157-167.
10. Parikh, A., Gillam, E. M. J., and Guengerich, F. P. (1997) Drug metabolism by Escherichia coli expressing human cytochromes P450. Nat. Biotechnol. 15, 784-788.
11. Cuttle, L., Munns, A. J., Hogg, N. A., Scott, J. R., Hooper, W. D., Dickinson, R. G., and Gillam, E. M. J. (2000) Phenytoin metabolism by human cytochrome P450: Involvement of P450 3A and 2C forms in secondary metabolism and drug-protein adduct formation. Drug Metab. Dispos. 28, 945-950.
12. Gillam, E. M. J., Baba, T., Kim, B.-R., Ohmori, S., and Guengerich, F. P. (1993) Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch. Biochem. Biophys. 305, 123-131.
13. 5. Arch. Biochem. Biophys. 348, 107-115.
14. Kaminsky, L. S., and Guengerich, F. P. (1985) Cytochrome P-450 isozyme/isozyme functional interactions and NADPH-cytochrome P-450 reductase concentrations as factors in microsomal metabolism of warfarin. Eur. J. Biochem. 149, 479-489.
15. Shimada, T., Tsumura, F., Gillam, E. M. J., Guengerich, F. P., and Inoue, K. (2000) Roles of NADPH-P450 reductase in the O-deethylation of 7-ethoxycoumarin by recombinant human cyto-chrome P450 1B1 variants in Escherichia coli. Protein Express. Purif. 20, 73-80.
16. 5 in bacterial membranes. Drug Metab. Dispos. 27, 999-1004.
17. 5 interactions. Arch. Biochem. Biophys. 342, 329-337.
18. 5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. J. Biol. Chem. 273, 3158-3165.
19. 5 with cytochromes P4503A4 and P45017A: Relevance of heme transfer reactions. Biochemistry 40, 5018-5031.
20. 5 effects vary with substrate. Arch. Biochem. Biophys. 385, 311-321.
21. Komatsu, T., Yamazaki, H., Asahi, S., Gillam, E. M. J., Guengerich, F. P., Nakajima, M., and Yokoi, T. (2000) Formation of a dihydroxy metabolite of phenytoin by human liver microsomes/ cytosol: Roles of cytochrome P450 2C9, 2C19, and 3A4. Drug Metab. Dispos. 28, 1361-1368.
22. Gillam, E. M. J., Aguinaldo, A. M. A., Notley, L. M., Kim, D., Mundkowski, R. G., Volkov, A. A., Arnold, F. H., Soucek, P., DeVoss, J. J., and Guengerich, F. P. (1999) Formation of indigo by recombinant mammalian cytochrome P450. Biochem. Biophys. Res. Commun. 265, 469-472.
23. Guengerich, F. P., Martin, M. V., Guo, Z., and Chun, Y.-J. (1996) Purification of functional recombinant P450s from bacteria. Methods Enzymol. 272, 35-44.
24. Dong, M.-S., Yamazaki, H., Guo, Z., and Guengerich, F. P. (1996) Recombinant human cytochrome P450 1A2 and N-terminal-truncated form: Construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase. Arch. Biochem. Biophys. 327, 11-19.
25. Shimada, T., Wunsch, R. M., Hanna, I. H., Sutter, T. R., Guengerich, F. P., and Gillam, E. M. J. (1998) Recombinant human cytochrome P450 1B1 expression in Escherichia coli. Arch. Biochem. Biophys. 357, 111-120.
26. Guengerich, F. P., Wang, P., and Mason, P. S. (1981) Immunological comparison of rat, rabbit, and human liver NADPH-cytochrome P-450 reductase. Biochemistry 20, 2379-2385.
27. 5. Methods Enzymol. 52, 97-101.
28. 5. J. Biol. Chem. 271, 27438-27444.
29. Guengerich, F. P. (1994) Analysis and characterization of enzymes in "Principles and Methods of Toxicology" (Hayes, A. W., Ed.), pp. 1259-1313, Raven Press, New York.
30. Shimada, T., Tsumura, F., and Yamazaki, H. (1999) Prediction of human microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone using kinetic parameters of recombinant cytochrome P450 enzymes. Drug Metab. Dispos. 27, 1274-1280.
31. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., and Guengerich, F. P. (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270, 414-423.
32. Inoue, K., Yamazaki, H., Imiya, K., Akasaka, S., Guengerich, F. P., and Shimada, T. (1997) Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4′-hydroxylation activities in livers of Japanese and Caucasian populations. Pharmacogenetics 7, 103-113.
33. Yamazaki, H., Inoue, K., Hashimato, M., and Shimada, T. (1999) Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. Arch. Toxicol. 73, 65-70.
34. Yamazaki, H., Shibata, A., Suzuki, M., Nakajima, M., Shimada, N., Guengerich, F. P., and Yokoi, T. (1999) Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P450 2C8 and P450 3A4 in human liver microsomes. Drug Metab. Dispos. 27, 1260-1266.
35. Omura, T., and Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239, 2370-2378.
36. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
37. Guengerich, F. P., Wang, P., and Davidson, N. K. (1982) Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochemistry 21, 1698-1706.
38. Iwatsubo, T., Hirota, N., Ooie, T., Suzuki, H., Shimada, N., Chiba, K., Ishizaki, T., Green, C. E., Tyson, C. A., and Sugiyama, Y. (1997) Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. Pharmacol. Ther. 73, 147-171.
39. Rodrigues, A. D. (1999) Integrated cytochrome P450 reaction phenotyping. Attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes. Biochem. Pharmacol. 57, 465-480.
40. 5, NADPH- P450 reductase, and lipid on the rate of 6b-hydroxylation of testosterone as catalyzed by a human P450 3A4 fusion protein. Arch. Biochem. Biophys. 318, 314-321.